Marketplace®

Daily business news and economic stories
May 24, 2022

A COVID treatment for vulnerable Americans isn’t getting to them

Lack of outreach and unequal distribution has left millions without protection. Plus, how massive container ships have exacerbated supply chain woes.

Download
Employees work at the assembly line of the manufacturing facility of pharmaceutical company AstraZeneca for biological medicines in Södertälje, south of Stockholm, Sweden on February 8, 2022. - AstraZenecas new facility in Sweden located in Södertälje was inaugurated last December and is dedicated to the production of next generation biological drugs such as Evusheld, a Covid-19 preventative monoclonal antibody treatment for immunocompromised people. 
Employees work at the assembly line of the manufacturing facility of pharmaceutical company AstraZeneca for biological medicines in Södertälje, south of Stockholm, Sweden on February 8, 2022. - AstraZenecas new facility in Sweden located in Södertälje was inaugurated last December and is dedicated to the production of next generation biological drugs such as Evusheld, a Covid-19 preventative monoclonal antibody treatment for immunocompromised people. 
Jonathan Nackstrand/AFP via Getty Images

Subscribe:

Segments From This Episode

Music from the episode

The Team

A COVID treatment for vulnerable Americans isn’t getting to them